News
02-02-2011, 10:00 PM
Vermillion, a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Biomarkers for breast cancer" to the Company.
More... (http://www.news-medical.net/news/20110202/USPTO-issues-notice-of-allowance-to-Vermillions-breast-cancer-biomarkers.aspx)
More... (http://www.news-medical.net/news/20110202/USPTO-issues-notice-of-allowance-to-Vermillions-breast-cancer-biomarkers.aspx)